OCT Technology Development to Assess Ocular Integrity and Characterize Ocular Integrity and Intraocular Scatterers
1 other identifier
interventional
14
1 country
1
Brief Summary
The purpose of this study is to develop and demonstrate new technologies that will enable a non-contact, compact eye imaging system based on OCT to assist an early responder in acute care settings (like an emergency room) to help assess eye trauma and inflammation (swelling inside the eye).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2018
CompletedFirst Posted
Study publicly available on registry
May 22, 2018
CompletedStudy Start
First participant enrolled
November 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2021
CompletedJune 27, 2022
June 1, 2022
2.3 years
May 9, 2018
June 22, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Concordance
By the ability to detect cells in the eye compared to clinical exam
Up to 18 months
Study Arms (1)
Imaging patients
EXPERIMENTALGet uveitis patients and ER patients to image their eyes
Interventions
Eligibility Criteria
You may qualify if:
- \- Pre-clinical: employees or students (over the age of 18) of the Duke Eye Center or Biomedical Engineering willing to be imaged with OCT system
- \- Pilot (ER): patients (over the age of 18) presenting emergently to the Duke Emergency room with traumatic eye injuries and/or suspected open globe
- \- Pilot (Uveitis): patients presenting to the Duke Eye Center with active uveitis and microhyphema or hyphema; patients who have independently consented to undergo vitreous tap or biopsy for their uveitis care at the Duke Eye Center
You may not qualify if:
- \- Pre-clinical: subject cannot be a direct report to any of the PIs or other key personnel of this study
- \- Pilot (ER): hemodynamically unstable, unable to consent
- \- Pilot (Uveitis): unable to consent; cornea or lens opacity/scar which would block the imaging modality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27705, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anthony Kuo, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2018
First Posted
May 22, 2018
Study Start
November 14, 2018
Primary Completion
March 10, 2021
Study Completion
March 10, 2021
Last Updated
June 27, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share